Superior Planning LLC’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$29.2K Buy
+207
New +$29.5K 0.01% 548

Other funds holding PTGX

Superior Planning LLC's PTGX Position: Q3 2026 in Review

Superior Planning LLC opened a new position in Protagonist Therapeutics (PTGX) in Q3 2026: 207 shares worth $29.2K. The stake represents 0.01% of the portfolio and ranks #548 among its holdings.

307 funds tracked by Wall St. Rank hold PTGX as of Q3 2026.

  • Superior Planning LLC held 207 shares of Protagonist Therapeutics worth $29.2K as of Q3 2026.
  • Protagonist Therapeutics was a new Superior Planning LLC position in Q3 2026.
  • Protagonist Therapeutics made up 0.01% of Superior Planning LLC's portfolio in Q3 2026, its #548 holding.
  • 307 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q3 2026.

Based on Superior Planning LLC's 13F filing for Q3 2026, filed 12 Nov 2026.